Abstract: Endometriosis impacts 190 million people worldwide, causing chronic debilitating pelvic pain and infertility. Current treatment strategies are limited, and most diagnoses involve invasive surgery. Macrophages are central to the pathophysiology of endometriosis. During the seminar I will describe the work we are doing to illuminate how monocytes and macrophages can be exploited for therapeutic and diagnostic purposes for endometriosis.

Biography: After completing her PhD at the University of Leeds (UK) in 2009, Dr Erin Greaves undertook postdoctoral training at the University of Edinburgh at the (then) MRC Human reproductive Sciences Unit. In 2015 she set up her lab at the MRC Centre for Reproductive Health, University of Edinburgh with a prestigious MRC Career Development Award Fellowship. In 2019 she was recruited to the University of Warwick. Erin’s’ main research interests are the role of macrophages in the pathogenesis of endometriosis and how they can be exploited for diagnostic and therapeutic purposes. She has had continued MRC support for the lab since its inception.

Externally, Erin was elected on to the inaugural Early Career World Endometriosis Society (WES) board in 2018, is immediate past chair of the EC WES board, and is a WES ambassador. She was appointed as assistant secretary for the senior WES board in 2022. She is also co-lead for the World Endometriosis Research Foundation (WERF) Experimental Models in Endometriosis Research initiative and was elected on to the WERF board in August 2022